Summary.-I.p. administration of 14 mg Corynebacterium parvum (C. parvum) 24 h before inoculation of Landschutz ascites carcinoma (LAC) cells significantly impaired growth of the tumour in MF1 mice. The injection of tumour cells caused a transient inhibition of the activity of the mononuclear phagocyte system (MPS) in both normal and C. parvum-treated hosts, as evidenced by impaired clearance of colloidal carbon from the bloodstream and reduction in hepatic phagocytosis of 51Cr-labelled sheep erythrocytes. Depression in Kupffer-cell activity was associated with a shift in particle distribution towards the spleen. The pronounced hepatosplenomegaly in response to C. parvum was significantly less in animals which also received tumour cells. Histological examination of liver and spleen revealed evidence of depressed MPS activity. Granuloma production in the liver in response to C. parvum was inhibited in tumour-bearing mice, and macrophage proliferation within the spleen was also reduced. Ascitic fluid showed similar inhibitory effects to those of tumour-cell suspensions, suggesting production by LAC of a heat-stable macrophageinhibitory factor.
THE CAPACITY of Corynebacterium parvum (C. parvum) to increase host resistance to experimental tumours is well documented (Milas & Scott, 1978) . This property is generally attributed to the marked stimulation of the mononuclear phagocyte system (MPS) by the microorganism (Halpern et al., 1963; Adlam & Scott, 1973) .
There is substantial evidence that macrophages play an important role in tumour immunity (Levy & Wheelock, 1974; Alexander, 1976; Weinberg & Hibbs, 1978) and it has been suggested that they are mediators of immunological surveillance (Alexander, 1976) . However, there are reports (reviewed by James, 1977 and North et al., 1978) that malignant tumour cells, or their soluble products, can interfere with normal macrophage functions, such as phagocytosis, bacterial resistance and chemotaxis. As yet, there is little information on the influence of tumour carriage on MPS activity in animals treated with C. parvum or other immunotherapeutic agents. In this paper we report the influence of the Landschutz ascites carcinoma on MPS activity in normal and C. parvum-injected mice. We have also attempted to verify the observation of Hrsak & Marotti (1974) and Normann (1978) (Normann, 1978 (Sljivi6, 1970) .
Distribution of 51Cr-labelled SRBC. Sheep red blood cells obtained from blood in Alsever's solution (Difco Laboratories) were washed x 3 in ice-cold PBS (pH 7.2) and labelled with 51Cr (sodium chromate B.P., Radiochemical Centre, Amersham, England) on the day of the experiment. To 041 ml packed erythrocytes was added 75 ,uCi in 0 3 ml PBS and the mixture incubated at room temperature for 1 h. After 4 washes, a 10% erythrocyte suspension was prepared and 0-1 ml injected i.v. via a lateral tail vein. Mice were killed by cervical dislocation 1 h after injection and livers and spleens dissected out. Excess blood was removed with filter paper, and whole organs placed in 5ml plastic tubes (Sarstedt, West Germany). Radio parvum-injected animals (5.7 + 0*7 x 108) was significantly lower (P < 0.0005) than that (9.9 + 2.1 x 108) in saline-injected controls.
Effects of C. parvum and tumour on organ weights
Liver weights in mice injected with C. parvum or tumour, and in animals given C. parvum 24 h before tumour are shown in Fig. 1 animals bearing tumour until Day 11. Tumour alone caused no further significant liver enlargement after Day 4. Animals injected with C. parvum also showed pronounced splenomegaly (Fig. 2) , a significant weight increase being recorded on Day 4 (P < 0.0025), with further highly significant increases on Days 7 and 11. There was no dramatic increase in spleen weight in those animals injected with C. parvum and tumour; although small but significant increases, compared to normal animals, were observed in this group on Days 4 and 7 (P < 0.05) the values did not differ from those in mice given tumour alone. By Day 11, however, there was a significant difference in spleen weights between the latter two groups, due principally to atrophy of the spleen in animals given tumour alone.
Histological appearances of liver and spleen
Typical periportal and parenchymal lymphohistiocytic inflammation with wellrounded granulomas was observed in livers of C. parvum-injected mice examined 5-12 days after injection of the microorganism (Fig. 3a) . Animals which also received tumour showed a marked reduction in the degree of inflammatorycell infiltration and a striking reduction in granuloma formation (Fig. 3b) . In the spleen, the degree of macrophage proliferation, constituting the mantle zone, which was very pronounced in response to C. parvum (Fig. 4a) , was markedly reduced in animals which also received tumour (Fig. 4b) . Examination of Gram-and Twort-stained sections of liver and spleen from all C. parvum-injected animals revealed the microorganism within mononuclear phagocytes. The presence of tumour did not affect the uptake or distribution of the microorganism within these tissues.
Effect of C. parvum and tumour on phago-
The influence of C. parvum on the rate of clearance of colloidal carbon from the bloodstream, and the effect of tumour Effect of ascites ftuid and C. parvum on K and organ distribution of 5lCr-SRBC Injection of 1 ml normal mouse serum (NMS) i.p. 24 h previously had no effect on K or the organ distribution of labelled SRBC (Table II) . In contrast, i.p. injection of 1 ml fresh or heat-treated cell-free ascites fluid caused a significant depression in K and hepatic uptake of SRBC. This was accompanied by increased phagocytic activity in the spleen.
In mice treated with C. parvum, 24 h or 4 days before carbon or SRBC injection, ascitic fluid also depressed K, with attendant increases in the proportion of SRBC incorporated within the spleen. This depression in hepatic phagocytosis resulting from injection of ascitic fluid was transient, however, since 3 days after its injection K values in either saline-or C. parvum-treated mice were restored to normal (data not presented).
DISCUSSION
In this study we have confirmed the potent reticuloendothelial activating properties of C. parvum, and have found, in keeping with Castro (1 974b The ability of LAC to reduce hepatosplenomegaly in C. parvum-injected mice itself suggests that the tumour influences the response of liver and spleen to the microorganism. Changes induced by C. parvum include Kupffer-cell proliferation and recruitment of mononuclear phagocytes (Castro, 1974a; McBride et al., 1974; Sljivic & Warr, 1975) , production of granulomas within the liver (Halpern et al., 1963; Sljivic & Warr, 1975) and pronounced expansion of the splenic red and white pulp (McBride et al., 1974; . Clearly, a reduction in intensity of these changes would produce less marked hepatosplenomegaly, and indeed our histological observations confirm that this was the case. It may be argued that the reduction in cell proliferation and granuloma production could (Eccles & Alexander, 1974; Snyderman et al., 1975; Meltzer & Stevenson, 1977) . In addition, key responses of macrophages, such as phagocytosis of opsonized red cells, chemotactic migration, bacterial resistance and their participation in anti-tumour immunity are affected by tumours or their extracts (Pike & Snyderman, 1976; Meltzer & Stevenson, 1977; Normann & Sorkin, 1976; North et al., 1978; . We have shown in this study that LAC inhibits phagocytic activity, measured systemically in terms of colloid clearance from the blood, in both normal and C. parvum-injected mice. WNlheelock, 1975; Fowler & Thomson, 1978) .
The capacity of ascitic fluid to depress phagocytic activity observed in this study is consistent with the work of Hrsak & Marotti (197:3, 1974) , who found that a single i.p. injection of Ehrlich ascites carcinoma fluid impaire(d hepatic and splenic phagocytosis, and caused prolonged suppression of humoral im m unity. Others have reported that ascitic fluid from the same tumour inhibits skin allograft rejection in the mouse (McCarthy et al., 1968) . These findings led Hrsak & Marotti (1974) to suggest thlat Ehrlich ascites tumouir fluiid contains a factor, stuch as that described earlier by Holmberg (1962) which inhibits antigen handling by macrophages. It seems likely that a similar factor may be responsible for depression of macrophage activity in the present study. Characterization of the active component(s) an(d its possible resemblance to 502 other anti-inflammatory tumour products already described (James, 1977) is currently under investigation in this laboratory.
